Scientific updates

Recent developments in research

• 
  News from WCLCOctober 6, 2026
• 
  Research summary: resistance to sevabertinib in HER2+ NSCLCSeptember 15, 2026
• 
  18-month update: targeting mSWI/SNF in KRAS+ lung cancerSeptember 13, 2026
• 
  CROWN Trial: 7-year updateJuly 10, 2026
• 
  Work presented at ASCO meeting could impact lung cancer treatmentJuly 2, 2026
• 
  CAR T-cell therapy for lung cancerJune 4, 2026

---

Science Made Simple

• 
  News from WCLCOctober 6, 2026
• 
  Sevabertinib for HER2+ lung cancerSeptember 14, 2026
• 
  Zidesamtinib for ROS1+ NSCLCAugust 3, 2026
• 
  CROWN Trial: 7-year updateJuly 10, 2026
• 
  Work presented at ASCO meeting could impact lung cancer treatmentJuly 2, 2026
• 
  CAR T-cell therapy for lung cancerJune 4, 2026
• 
  Zongertinib approved as first-line HER2+ lung cancer treatmentApril 24, 2026
• 
  AI for Lung Cancer ScreeningMarch 30, 2026
• 
  Lung cancer in 2025January 28, 2026

---

Recent FDA approvals